Charles Russell Speechlys advises Kreos on growth capital investment in biotech company JenaValve Technologies, Inc.
Charles Russell Speechlys has advised Kreos Capital V (UK) Limited (“Kreos”) on its growth capital investment in JenaValve Technologies, Inc., a biotech company founded to develop next generation transcatheter aortic valve replacement systems for transapical and transfemoral implantation.
By virtue of its anatomically-based locator fixation and dual sealing valve design, the JenaValve Pericardial TAVR System is intended to enable ease of use, reduced risks of paravalvular regurgitation and need for permanent pacing, and durability of patient hemodynamic outcomes.
The Charles Russell Speechlys team was led by Corporate Legal Director Rossana Conti and comprised Banking Partner Daniel Sullivan and Banking Associate Roya Zohrabi. Our team worked in collaboration with Golenbock Eiseman Assor Bell & Peskoe LLP, a US law firm.
This deal further showcases the growing breadth and depth of our Life Sciences practice.
Bond Clarke and Charles Russell Speechlys act on sale of person-centred software to cow corner
PCS is an award-winning company, founded in 2013 to help improve the quality of life for people in social care.
The Chartered Institution of Taxation (CIOT) Budget representations for October 2021
The CIOT has recommended an extension of the EMI scheme and a fairly comprehensive review of the rules underpinning EOT relief.
Insolvencies and rising prices: the energy retail market in flux
Hanh and Sara take a look at the energy market
Charles Russell Speechlys successfully advises the Joint Liquidators of LB GP No.1 Ltd in Lehman Brothers litigation before the Court of Appeal
LBGP is a company within the Lehman Brothers Group, whose purpose was to raise regulatory capital for parts of the Group.
Charles Russell Speechlys welcomes David Collins as new Divisional Managing Partner
The firm announces the appointment of David Collins as new Divisional Managing Partner for Business Advisory & Transaction Services.
Charles Russell Speechlys advises shareholders of eCommonSense on sale to ECI Software Solutions
eCommonSense is a technology solutions provider focused on the construction and building materials supply sectors.
Amelia Goodwin and Georgina O'Sullivan write for P3 Pharmacy on the key to managing performance
Day-to-day management is time consuming enough, so if you have a workforce with no apparent issues, performance may not be on your radar.
Charles Russell Speechlys wins best Legal Services: Private Equity at the Africa Global Funds Awards 2021
We are delighted to announce we have been awarded the Legal Services: Private Equity award at the AGF Service Providers Awards 2021.
Charles Russell Speechlys advises Silbury Finance on a £55m facility to a Jersey unit trust
Silbury provides real estate development finance for professional developers seeking to acquire and build in the UK.
Charles Russell Speechlys acts for Cmostores Group Limited on its acquisition of JTM Plumbing Limited
CMO Group Plc, UK’s largest pureplay online retailer of building materials which recently listed on AIM.
Charles Russell Speechlys advises the founders of Compandben on the sale of the business to TopSource Worldwide
Compandben is one of the longest established international providers of employment solutions.
The importance of anticipating the restructuring of State Guaranteed Loans
Denis looks at the importance of anticipating the restructuring of State Guaranteed Loans
Charles Russell Speechlys Hong Kong successfully defends equal opportunities action brought against Novartis
We have successfully defended NYSE-listed healthcare company Novartis against an equal opportunities action filed by a former employee.
Victoria Younghusband, Jessica Arrol Caws and Giulia Brunello write for The Bahamas Financial Services Board 's GATEWAY Magazine on the role of IFC's in the post-Brexit environment
Victoria and Jessica consider the changing role for IFCs following the approval of the Trade and Cooperation Agreement.
Pharmacy Brief - September 2021
The September edition of our Pharmacy Brief
Phase out of temporary restrictions on use of winding up petitions
Hannah takes a look at the recent UK Government announcement on statutory demands and the presentation of winding up petitions
Preparing your company for sale
We set out here some initial steps to consider in anticipation of a sale.
Overhaul of London's stock market listing regime set to significantly boost capital raising opportunities for founder led UK tech businesses
Charles Russell Speechlys advises discoverIE on its acquisition of Antenova
discoverIE is a leading international designer, manufacturer and supplier of customised electronics to industry.
Charles Russell Speechlys advises Acora on acquisition of Westgate IT
Westgate IT specialises in providing IT support to businesses in the South West.